Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
Aaron P MitchellAkriti MishraPranam DeyMichael A CurryNiti U TrivediMichael HaddadinMohammed W RahmanAaron N WinnStacie B DusetzinaPeter B BachPublished in: The oncologist (2021)
Oncologists who author clinical practice guidelines frequently have financial conflicts of interest with the pharmaceutical industry. This creates concern about the potential for industry influence on guidelines. However, it is unknown whether oncologists who author guidelines have greater industry relationships than their peers. This study compared medical oncologists who were newly selected to join a National Comprehensive Cancer Network (NCCN) Guidelines panel with medical oncologists at the same institutions and at similar career stages. At the time they joined, oncologists joining NCCN Guidelines panels had received more than three times the dollar value of industry payments than their peers. The potential for industry influence may be reduced by the selection of less-conflicted panel members.